Neonatal co-lesion by DSP-4 and 5,7-DHT produces adulthood behavioral sensitization to dopamine D2 receptor agonists

Pharmacological Reports

Volumn 61, Issue 2, 2009, Pages 311-318

  Nowak, Przermysław ^a   Nitka, Dariusz ^a   Kwieciński, Adam ^a   Jośko, Jadwiga ^a   Drab, Jacek ^a   Pojda Wilczek, Dorota ^a   Kasperski, Jacek ^a   Kostrzewa, Richard M ^b   Brus, Ryszard ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b East Tennessee State University   (United States)

Author keywords

5 7 DHT; Behavior; Biogenic amines; Brain; Dopaminergic; DSP 4; Rats

Indexed keywords

2 BROMO N (2 CHLOROETHYL) N ETHYLBENZYLAMINE; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 5,7 DIHYDROXYTRYPTAMINE; AMPHETAMINE; APOMORPHINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; NORADRENALIN; QUINPIROLE; SEROTONIN; BENZYLAMINE DERIVATIVE; DOPAMINE RECEPTOR STIMULATING AGENT;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC ACTIVITY; DRUG DOSE ESCALATION; DRUG SENSITIZATION; FRONTAL CORTEX; HIPPOCAMPUS; LOCOMOTION; MALE; NEUROTOXICITY; NONHUMAN; NORADRENERGIC NERVE; ONTOGENY; RAT; SEROTONINERGIC NERVE CELL; WISTAR RAT; YAWNING; ANIMAL; DRUG EFFECT; DRUG POTENTIATION; EXPLORATORY BEHAVIOR; MOTOR ACTIVITY; NEWBORN; PHYSIOLOGY;

5,7-DIHYDROXYTRYPTAMINE; ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; BENZYLAMINES; DOPAMINE AGONISTS; EXPLORATORY BEHAVIOR; MALE; MOTOR ACTIVITY; NOREPINEPHRINE; QUINPIROLE; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2; SEROTONIN;

EID: 67650249184     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(09)70037-4     Document Type: Article

References (33)

1. Allen SM, Davis WM: Relationship of dopamine to serotonin in the neonatal 6-OHDA rat model of Lesch-Nyhan syndrome. Behav Pharmacol, 1999, 10, 467-474.
2. Alttoa A, Eller M, Herm L, Rinken A, Harro J: Amphetamine-induced locomotion, behavioral sensitization to amphetamine, and striatal D2 receptor function in rats with high or low spontaneous exploratory activity: differences in the role of locus coeruleus. Brain Res, 2007, 1131, 138-148.
3. Alttoa A, Kõiv K, Eller M, Uustare A, Rinken A, Harro J: Effects of low dose N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine administration on exploratory and amphetamine-induced behavior and dopamine D2 receptor function in rats with high or low exploratory activity. Neuroscience, 2005, 132, 979-990.
4. Baumgarten HG, Björklund A, Lachenmayer L, Nobin A, Stenevi U: Long-lasting selective depletion of brain serotonin by 5,6-dihydroxytryptamine. Acta Physiol Scand, 1971, 373 (Suppl.), 1-16.
5. Baumgarten HG, Lachenmayer L: 5,7-dihydroxytryptamine. Improvement in chemical lesioning of indoleamine neurons in the mammalian brain. Z Zellforsch, 1972, 135, 399-414.
6. Bortel A, Nowak P, Brus R: Neonatal DSP-4 treatment modifies GABAergic neurotransmission in the prefrontal cortex of adult rats. Neurotox Res, 2008, 13, 247-252.
7. Bortel A, Słomian L, Nitka D, Świerszcz M, Jaksz M, Adamus-Sitkiewicz B, Nowak P et al.: Neonatal N-(2 -chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) treatment modifies the vulnerability to phenobarbitaland ethanol-evoked sedative-hypnotic effects in adult rats. Pharmacol Rep, 2008, 60, 331-338.
8. Brus R, Kostrzewa RM, Perry KW, Fuller RW: Supersensitization of the oral response to SKF 38393 in neonatal 6-hydroxydopamine-lesioned rats is eliminated by neonatal 5,7-dihydroxytryptamine treatment. J Pharmacol Exp Ther, 1994, 268, 231-237.
9. Brus R, Nowak P, Labus Ł, Bortel A, Dabrowska J, Kostrzewa RM: Neonatal lesion of noradrenergic neurons in rat brain: Interaction with the dopaminergic system. Pol J Pharmacol, 2005, 57, 270-271 (abstract).
10. Brus R, Plech A, Kostrzewa RM: Enhanced quinpirole response in rats lesioned neonatally with 5,7-dihydroxytryptamine. Pharmacol Biochem Behav, 1995, 50, 649-653.
11. Chia LG, Ni DR, Cheng FC, Ho YP, Kuo JS: Intrastriatal injection of 5,7-dihydroxytryptamine decreased 5-HT levels in the striatum and suppressed locomotor activity in C57BL/6 mice. Neurochem Res, 1999, 24, 719-722.
12. Creese I, Iversen SD: Behavioral sequel of dopaminergic degenerations. In: Modern Pharmacology-Toxicology. Eds. Ellsodin JR, Bunney JR. Marcel Dekker Publ, New York, 1975, 3, 171-190.
13. 1A autoreceptors induced by neonatal DSP-4 treatment. Eur Neuropsychopharmacol, 2007, 17, 129-137.
14. 3 receptor ligand. Eur J Pharmacol, 1923, 249, R9-R10.
15. File SE, Pope JH: The action of chlorpromazine on exploration in pair rats. Psychopharmacologia, 1974, 37, 249-254.
16. Gong L, Kostrzewa RM: Supersensitized oral response to a serotonin agonist in neonatal 6-OHDA-treated rats. Pharmacol Biochem Behav, 1992, 41, 621-623.
17. Gong L, Kostrzewa RM, Fuller RW, Perry KW: Supersensitization of the oral response to SKF 38393 in neonatal 6-OHDA-lesioned rats is mediated through a serotonin system. J Pharmacol Exp Ther, 1992, 261, 1000-1007.
18. Gong L, Kostrzewa RM, Perry KW, Fuller RW: Dose-related effects of a neonatal 6-OHDA lesion on SKF 38393- and m-chlorphenylpiperazine-induced oral activity response of rats. Dev Brain Res, 1993, 76, 233-238.
19. Harro J, Meriküla A, Lepiku M, Modiri AR, Rinken A, Oreland L: Lesioning of locus coeruleus projections by DSP-4 neurotoxin treatment: effect on amphetamine-induced hyperlocomotion and dopamine D2 receptor binding in rats. Pharmacol Toxicol, 2000, 86, 197-202.
20. Kostrzewa RM: Mechanisms of action of 6-hydroxydopamine, a dopaminergic neurotoxin. In: Mechanisms of Degeneration and Protection of the Dopaminergic System. Ed. Segura-Aguilar J. FP Graham Publishing Co., Johnson City, TN, USA. 2001, 88-104.
21. 3 mediated event? Life Sci, 1991, 48, 129.
22. Kostrzewa RM, Brus R: Ontogenic homologous supersensitization of quinpirole-induced yawning in rats. Pharmacol Biochem Behav, 1991, 39, 517-519.
23. Kostrzewa RM, Jacobowitz DM: Pharmacological actions of 6-hydroxydopamine. Pharmacol Rev, 1974, 26, 199-208.
24. Kostrzewa RM, Reader TA, Descarries L: Serotonin neural adaptations to ontogenic loss of dopamine neurons in rat brain. J Neurochem, 1998, 70, 889-898.
25. Lehmann O, Jeltsch H, Lehnardt O, Pain L, Lazarus C, Cassel JC: Combined lesions of cholinergic and serotonergic neurons in the rat brain using 192 IgG-saporin and 5,7-dihydroxytryptamine: neurochemical and behavioural characterization. Eur J Neurosci, 2000, 12, 67-79.
26. Lin Y, Quartermain D, Dunn AJ, Weinshenker D, Stone EA: Possible dopaminergic stimulation of locus coeruleus alpha1-adrenoceptors involved in behavioral activation. Synapse, 2008, 62, 516-523.
27. Magnusson O, Nilsson LB, Westerlund D: Simultanous determination of dopamine, DOPAC and homovanillic acid. Direct injection of supernatants from brain tissue homogenates in a liquid chromatography-electrochemical detection system. J Chromatogr, 1980, 221, 237-247.
28. Makihara Y, Yamamoto H, Inoue M, Tomiyama K, Koshikawa N, Waddington JL: Topographical effects of D1-like dopamine receptor agonists on orofacial movements in mice and their differential regulation via oppositional versus synergistic D1-like: D2-like interactions: cautionary observations on SK&F 82958 as an anomalous agent. J Psychopharmacol, 2004, 18, 484-495.
29. Nowak P, Jochem J, Zwirska-Korczala K, Josko J, Noras L, Kostrzewa RM, Brus R: Ontogenetic noradrenergic lesion alters histaminergic activity in adult rats. Neurotox Res, 2008, 13, 79-83.
30. Nowak P, Labus Ł, Kostrzewa RM, Brus R: DSP-4 prevents dopamine receptor priming by quinpirole. Pharmacol Biochem Behav, 2006, 84, 3-7.
31. Okuyama S, Shimamura H, Hashimoto S, Aihara H: Relation between yawning behavior and central serotonergic neuronal system in rats. Naunyn Schmiedebergs Arch Pharmacol, 1987, 335, 667-672.
32. Ross SB: Long-term effect of N-2-chlorethyl-N-ethyl-2-bromobenzylamine hydrochloride on noradrenergic neurons in the rat brain and heart. Br J Pharmacol, 1976, 50, 521-527.
33. Tranzen JP, Thoenen H: An electron microscopic study of selective, acute degeneration of sympathetic nerve terminals after administration of 6-hydroxydopamine. Experientia, 1967, 24, 155-156.